Author Archives: Stefan Avall

Kardium announces enhanced clinical capabilities of the Globe® System with Right Atrial ablation and Hybrid Energy ablation

05/09/2024

Vancouver, BC — Kardium Inc., a private medical device company that has developed the Globe® System for the treatment of atrial fibrillation (AF), announced today that it had successfully treated a series of patients delivering therapy in both the left and right atria.  After successfully completing pulmonary vein isolation (PVI) and posterior wall ablation in […]

Read More

Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Study

04/02/2024

(Vancouver | April 2, 2024) — Kardium Inc., a private medical device company that has developed the Globe® System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today the successful completion of enrollment in the paroxysmal cohort of the pivotal PULSAR IDE (Investigational Device Exemption) study. This achievement marks a […]

Read More

Kardium Announces First US Procedures in PULSAR Study of Globe® Pulsed Field System

05/31/2023

(Vancouver | May 31, 2023) Kardium Inc., a private medical device company that has developed the Globe System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today that the first US patients have been successfully treated in the PULSAR clinical study. The PULSAR study will enroll over 400 patients for […]

Read More